Vermont health commissioner outlines budget-adjustment requests for abortion medication stock, prevention programs and health-equity grants

Dr. Mark Levine, commissioner of the Vermont Department of Health, told a legislative budget hearing on Jan. 23 that the department is seeking several one-time budget adjustments to cover technology service costs, ensure continuity of reproductive-care medication access, expand substance-misuse prevention and fund health-equity community grants.

Levine said the department has three appropriations affected by the governor’s budget adjustment: administration and support; public health; and substance use. He described a $100,000 general-fund request to purchase a one-year stock of two medications used for medication abortion — mifepristone and misoprostol — to be held by Planned Parenthood of Northern New England “to help assure uninterrupted care, uninterrupted access to care for patients in Vermont.”

Why it matters: Levine and lawmakers discussed supply-chain risks and the practical effect of a short shelf life for one of the drugs. Committee members pressed whether Planned Parenthood would share doses with other providers if needed; Levine said hospitals maintain their own inventories but that, in prior similar actions, the state reviewed where it felt comfortable with supply levels. He said the department’s prior estimate put the per-dose cost at about $40–$50, and that a $100,000 appropriation would buy roughly 2,000 doses. He also said one drug in the pair has about a two-year shelf life, which limits the effective period of a state stockpile.

Levine framed the request in the context of potential national legal and regulatory changes, saying concerns include limits on importation and cross-state mail-order prescribing (a reference discussed in committee as “Comstock”-style restrictions). He said he would not speak beyond his medical expertise on legal questions, and repeated that decisions about sharing stock would depend on Planned Parenthood’s policies.

On substance-use prevention, Levine said the administration is requesting just over $1 million to reflect a larger-than-expected fiscal-year 2024 transfer into the cannabis regulation fund. Under current law cited by Levine, 30% of the year-end balance in the fund is earmarked for substance-misuse prevention services; the FY24 year-end transfer produced $4,025,125 in available funds for that purpose. The department plans to use the additional funds to expand evidence-based, school- and community-level strategies aimed at preventing substance misuse and improving geographic equity of services.

Levine said the law beginning in fiscal 2026 will direct up to 30% of cannabis excise-tax revenue to prevention programs, capped at $10 million a year, and that the budget adjustment accommodates the first year of that change.

The commissioner also described two other one-time requests: a $150,000 increase to complete a legislatively directed household health-insurance survey (bringing the contract total to $550,000) that Levine said will be fielded this year with a report expected in late spring; and a $500,000 transfer of one-time general funds from the Agency of Administration to the Department of Health to administer community grants through the newly established office of health equity. Levine described those grants as modest individual awards to community partners for outreach and services that advance health equity, and cited examples from the COVID response such as targeted testing, vaccination access and culturally tailored messaging.

Lawmakers asked about related subjects during the presentation. Committee members raised concerns about co-occurring mental-health and substance-use disorders and whether prevention funding would support training or workforce development; Levine said the prevention funds are primarily substance-misuse directed but that community organizations and school personnel working on prevention are attuned to co-occurring issues. He also discussed primary-care access, saying the department will publish a state health improvement plan in the next six months informed by the state health assessment, and acknowledged workforce and programmatic threats to primary care but did not announce new department actions beyond ongoing coordination across agencies.

On injury-prevention work, Levine described the department’s safe-storage outreach for firearms, distribution of locking devices and clinician-facing grand rounds done with partners including the Department of Veterans Affairs. He noted resources such as the 988 crisis line and the Facing Vermont website but said the department does not have the distribution counts for locking devices available in the hearing and offered to follow up with that data.

What the hearing recorded: these were requests presented by the Department of Health for committee consideration; the transcript records discussion and questions but no committee votes or formal appropriations enacted during the session.

The Department of Health presentation lasted through the committee’s question period before the body recessed for a scheduled break.